Web Search Site Search HCV Patient Assistance Programs (click here for details)   Ryan White Care Act Hepatitis C & B Language (click here for details)   HCV Copayment Assistance - HealthWell Foundation (click here for details)   European Resistance Workshop June-2015 / Clinical Pharmacology Workshop May-2015 / 11th Co-infection Workshop June 11-12 2015/London - Slide Presentations (click here for details)   NYS HIV SNPS - Medicaid Managed Care Plans called HIV Special Needs Plans & the HIV SNPS Discussion Group Online (click here for details)   Current HIV Articles and News Updates     HIV     IAS: HIV Prevention at IAS 2015 Vancouver - Jared Baeten, MD PhD Connie Celum, MD MPH University of Washington   The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trial - (02/19/16)   CCR2 inhibition: a panacea for diabetic kidney disease? - Comment - (02/19/16)   Will a new tenofovir prodrug for the treatment of HIV reduce the risk of nephrotoxicity? - (02/19/16)   Cancers / HIV - (02/19/16)   ART / Neurotoxicity - (02/19/16)   More HIV Articles...         News Updates     GSK's global HIV business ViiV Healthcare completes transactions to acquire Bristol-Myers Squibb's R&D HIV assets - (02/22/16)   Merck's Investigational Once-Daily Formulation of ISENTRESS® (raltegravir) Meets Primary and Secondary Endpoints in Pivotal Phase 3 Study - (02/22/16)   HHS Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents - (02/11/16)   NIH Funding Editorial - (02/11/16)   Johns Hopkins approved to perform HIV-positive to HIV-positive organ transplants - (02/11/16)   Johns Hopkins Wins Approval to Perform H.I.V.-Positive Organ Transplants - (02/11/16)   BUDGET EXACT LANGUAGE ON DRUG PRICING, $20 Mill for Prep, New Funding for HCV Screening/Care in HIV+ (I think its $9 mill) - (02/11/16)   HCV/HIV Coinfection New $9 Milion Federal Funded Program - (02/11/16)   Obama Releases FY 2017 Budget: [HHS] drug pricing, PrEP, HCV in HIV+ - (02/11/16)   Kidney Function 101 - (02/11/16)   Natural protein points to new inflammation treatment - (02/05/16)   Atlanta / Fulton Health Introduces New HIV Strategies-PrEP Clinic and Rapid Entry - (02/05/16)   ACS/Deductibles -Many Say High Deductibles Make Their Health Law Insurance All but Useless - (02/05/16)   Abbott to Acquire Alere, a Maker of Medical Tests - (02/05/16)   The Latest Study on Depo-Provera and HIV: Far More Complex Than Most Headlines Suggest - (02/05/16)   State Of Florida Ranks Highest In New HIV Cases In The US - (02/05/16)   HIV+ Life Insurance - HIV, CD4 counts and life insurance - (02/05/16)   More News Updates Articles...     Current Hepatitis C and B Articles     Hepatitis C     AASLD: Summary from AASLD 2015 for Hepatitis C Beyond 95% SVR cure rates: still room for improvement? - Jurgen K. Rockstroh M.D., Professor of Medicine University of Bonn, Germany -   Maribel Rodriguez-Torres, MD, Scientist, Puerto Rico Passes - (01/05/15)   APASL: GIFT-I: ALT CHANGES WITH OMBITASVIR/PARITAPREVIR/RITONAVIR AND CONCOMITANT USE OF HEPATOPROTECTIVES - (02/22/16)   APASL: High Efficacy of the Combination HCV Regimen Grazoprevir and Elbasvir for 8 or 12 weeks with or without Ribavirin in Treatment-NaÏve, Non-Cirrhotic HCV GT1b Infected Patients: an Integrated Analysis - (02/22/16)   APASL: Elbasvir/Grazoprevir in Cirrhotic Patients With HCV Infection - (02/22/16)   APASL: Sofosbuvir, Ledipasvir in IBD treated patients with advanced biologics including Ribavirineradicating Chronic Hepatitis C: SOLATAIRE CTrial. A multi-center clinical prospectivepilot study - (02/22/16)   APASL: GIFT-I: OMBITASVIR/PARITAPREVIR/RITONAVIR SAFETY AND EFFICACY IN RENALLY-IMPAIRED JAPANESE PATIENTS - (02/22/16)   APASL: GIFT-I: SAFETY AND EFFICACY OF OMBITASVIR/PARITAPREVIR/RITONAVIR IN ELDERLY JAPANESE PATIENTS - (02/22/16)   APASL: Evaluation of Daclatasvir and Asunaprevir Exposures in Japanese, Non Japanese Asians, and Non-Asians - (02/22/16)   APASL: EQ-5D Results in Asian Patients with HCV Genotype 1b Receiving Daclatasvir plus Asunaprevir who are Interferon Intolerant/Ineligible - (02/22/16)   APASL: FSS and SF-36 in Asian Patients with HCV Genotype 1b Receiving Daclatasvir and Asunaprevir and who are Interferon plus Ribavarin Intolerant or Ineligible - (02/22/16)   APASL: Daclatasvir+Asunaprevir versus Sofosbuvir/Ledipasvir for the Treatment of Chronic Hepatitis C Genotype 1 in Japanese Patients: A Matching-Adjusted Indirect Comparison - (02/22/16)   APASL: High SVR Rates With ABT-493 + ABT-530 in Non-Cirrhotic Patients With HCV Genotypes 1, 2, 3 Infection - (02/22/16)   APASL: SLAM C study Sofosbuvir and Ledipasvir versus Sofosbuvir and Simeprevir combination therapy in the management of acute hepatitis C: A randomized open label prospective clinical pilot study. (drug rehabs in NYC] - (02/22/16)   More Hep C Articles...         Hepatitis B     New HBV Drugs / New /HBV-Cyclophillin Inhibitor - (02/11/16)   New therapeutic agents for chronic hepatitis B - (02/09/16)   CDC: [HBV Epidemic/IDUs] Increases in Acute Hepatitis B Virus Infections - Kentucky, Tennessee, and West Virginia, 2006-2013 - (02/09/16)   More Hep B Articles...   Check Out Our Special NATAP Features   Link to conference listings 5th International Workshop on HIV & Women, from Adolescence through Menopause Saturday 21 and Sunday 22 February 2015 Renaissance Seattle Hotel 5th International Workshop on HIV & Women, from Adolescence through Menopause February 21-22, 2015 http://www.informedhorizons.com/resistance2015/ http://www.croiconference.org/ http://www.apasl2015.org/ 4th Latin American Meeting on Treatment of Viral Hepatitis and HIV Co-infection 20 March 2015 - 21 March 2015 Sao Paulo Brazil http://www.virology-education.com/event/ upcoming/4th-la-viral-hepatitis-workshop-2015/ HIV Americas Congress April 16-18 2015 Hotel Royal Pedregal Mexico City, Mexico http://www.hivamericas.org/ http://www.easl.eu/ https://ilc-congress.eu/ http://www.comtecmed.com/chep/2014/ May 2015 (Not Final) Location is not final The 3rd World Congress on Controversies in the Management of Viral Hepatitis (C-Hep 2014) was held in Berlin, Germany on May 1-3, 2014 DDW - Digestive Disease Week http://www.ddw.org/ 16th International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 26 - 28 May 2015 in Washington DC, USA http://www.virology-education.com/event/upcoming/ 16th-international-workshop-clinical- pharmacology-hiv-hepatitis-therapy/ 10th Hepatitis C Workshop 2015 http://www.virology-education.com/event/ upcoming/10th-hepc-workshop-2015/ 10th Hepatitis C Workshop 2015 will be organized as a half day program during the 13th European Meeting on HIV & Hepatitis (Barcelona, Spain, 3 - 5 June 2015). http://www.virology-education.com/ event/upcoming/11th-co-infection-workshop-2015// IAS 2013 - International AIDS Society July 19-22 2015 Vancouver http://www.ias2015.org/ http://viral-hep.org/ www.icaac.org/ HIV & Aging: 5 October 2015 - 6 October 2015 Washington, DC (tbc) USA http://www.virology-education.com/event/upcoming/ 6th-hiv-aging-workshop-2015/ http://www.idweekinternational.com/Home. aspx?gclid=Cj0KEQiA0aemBRC8p87zv_ mc5qYBEiQAiEEMQUCURIpSxbdexs 7TQX1lRY3sNd0GP1xGXXci8z2KMv0aAiGG8P8HAQ http://www.eacs-conference2015.com/index.php?article_id=1 October 21-24 2015, Barcelona http://www.intmedpress.com/comorbidities/ 2nd International Hepatitis Cure & Eradication Meeting 2015 11 November 2015 - 12 November 2015 http://www.virology-education.com/event/upcoming/2nd-international- hepatitis-cure-eradication-meeting-2015/ http://www.aasld.org/events-professional- development/liver-meeting-2015 Friday, November 13, 2015 to Tuesday, November 17, 2015 Moscone West Convention Center San Francisco, California http://www.hiv-persistence.com/ https://www.informedhorizons.com/hepdart2015/default.aspx APASL 25th Conference of the Asian Pacific Association for the Study of the Liver Feb 20-24 2016, Tokyo, Japan   HEPDART 2015: Frontiers in Drug Development for Viral Hepatitis December 6-10 2015 Wailea, HI   66th Annual Meeting of the American Association for the Study of Liver Diseases Boston, MA Nov 13-17 2015   (IWCADRH) 17th Intl Workshop on Comorbidities and Adverse Drug Reactions in HIV Oct 20-22 2015, Barcelona, Spain   15th European AIDS Conference (EACS) October 21-24, 2015 Barcelona   IDSA/IDWeek October 7-11 2015 San Diego   6th International Workshop on HIV and Aging October 5-6, 2015 Washington, DC   ICAAC 2015 55th Interscience Conference on Antimicrobial Agents and Chemotherapy September 5-9, 2015, San Diego, CA   IAS 2015: 8th IAS Conference on HIV Pathogenesis Treatment and Prevention Vancouver Canada 18-22 July 2015   16th International Workshop on Clinical Pharmacology of HIV and Hepatitis Therapy May 26-28, 2015 Washington, DC   DDW - Digestive Disease Week 2015 May 16-19, 2015 Washington DC United States   EASL - The International Liver Congress 2015 50th Annual Meeting of the European Association for the Study of the Liver Vienna, Austria April 22-26   The 24th Annual Meeting of the Asian Pacific Association for the Study of the Liver (APASL 2015) Istanbul, Turkey, March 12-15, 2015   22nd Conference on Retroviruses and Opportunistic Infections Seattle Washington Feb 23 - 26, 2015   65th Annual Meeting of the American Association for the Study of Liver Diseases Boston, MA Nov 7-11 2014   HIV Drug Therapy Glasgow November 2-6, 2014 Glasgow, UK   5th International Workshop on HIV and Aging. October 21-22, 2014 Baltimore   ACG Annual Scientific Meeting Philadelphia, PA, October 20, 2014   16th International Workshop on Co-Morbidities and Adverse Drug Reactions in HIV Philadelphia USA Oct 6-8, 2014   ID Week Oct 8-12 2014 Philadelphia   AASLD/EASL Special Conference on Hepatitis C New York City, New York September 12 - 13   ICAAC 2014 54th Interscience Conference on Antimicrobial Agents and Chemotherapy September 5-9, 2014 Washington, DC   20th International AIDS Conference July 20-25, 2014 Melbourne, Australia   International Workshop on Antiviral Drug Resistance June 3-7 2014, Berlin, Germany   15th International Workshop on Clinical Pharmacology of HIV and Hepatitis Therapy May 19- 21, 2014, Washington, DC   DDW - Digestive Disease Week 2014 May 4, 2014, Chicago Illinois, United States   EASL - The International Liver Congress 2014 49th Annual Meeting of the European Association for the Study of the Liver London, United Kingdom April 9-13   (APASL) 24th Conference of the Asian Pacific Association for the Study of the Liver Brisbane, Australia 12-15 March, 2014   21st Conference on Retroviruses and Opportunistic Infections Boston MA March 3 - 6, 2014   6th HIV Persistence during Therapy - Sixth International Workshop Miami, Dec 3-6, 2013   Fourth International Workshop on HIV and Women January 13-14, 2014 Washington DC   HEPDART 2013: Frontiers in Drug Development for Viral Hepatitis December 8-12, 2013 Big Island, Hawaii   64rd Annual Meeting of the American Association for the Study of Liver Diseases Washington, DC Nov 1-5 2013   4th International Workshop on HIV and Aging October 30-31, 2013 Baltimore, MD   14th European AIDS Conference Oct 16-19 2013 Brussels, Belgium   ID Week October 2-6, 2013 San Francisco   53rd ICAAC Interscience Conference on Antimicrobial Agents and Chemotherapy September 10-13 2013, Denver CO   IAS 2013: 7th IAS Conference on HIV Pathogenesis, Treatment and Prevention June 30 - July 3 2013 Kuala Lumpur, Malaysia   International Workshop on HIV & Hepatitis Virus Drug Resistance and Curative Strategies June 4-8, 2013 Toronto, Canada   (APASL) 23rd Conference of the Asian Pacific Association for the Study of the Liver 6-9 June, 2013, Singapore   Digestive Disease Week (DDW) May 18-21, 2013 Orlando, FL   14th International Workshop on Clinical Pharmacology of HIV Therapy April 22-24, 2013 The Netherlands, Amsterdam   EASL 48th Annual Meeting April 24th - 28th 2013 The Netherlands, Amsterdam   CROI: 20th Conference on Retroviruses and Opportunistic Infections Atlanta, GA March 3 - 6, 2013   Third International Workshop on HIV and Women January 14-15, 2013 Toronto 15th International Workshop on Co-morbidities and Adverse Drug Reactions in HIV Brussels, Belgium Oct 15-17 2013 11th International Congress on Drug Therapy in HIV Infection 11-15 November 2012 Glasgow, UK 63rd Annual Meeting of the American Association for the Study of Liver Diseases Boston, MA Nov 9-12 2012 3rd International Workshop on HIV and Aging November 5-6, 2012 Baltimore MD IDSA Conference (Infectious Disease Society Association) San Diego, CA Oct 17-21 2012 52nd ICAAC Interscience Conference on Antimicrobial Agents and Chemotherapy September 9-12, 2012, San Francisco XIX International AIDS Conference July 22-27, 2012 Washington, DC   14th International Workshop on Co-morbidities and Adverse Drug Reactions in HIV Washington DC, July 19-21 2012   International Workshop on HIV & Hepatitis Virus Drug Resistance 5-9 June 2012, Sitges, Spain   EASL 47th Annual Meeting Barcelona, Spain April 18th - 22nd 2012   13th International Workshop on Clinical Pharmacology of HIV Therapy Barcelona, Spain April 16-18, 2012   CROI: 19th Conference on Retroviruses and Opportunistic Infections Seattle, WA March 5 - 8, 2012   The 22st Conference of the Asian Pacific Association for the Study of the Liver APASL Feb 16-19, 2012 Taipei, Taiwan   2nd International Workshop on HIV & Women January 9-10, 2012 Bethesda, Maryland   HepDART 2011 Kauai, HI USA December 4, 2011 - December 8, 2011   62th Annual Meeting of the American Association for the Study of Liver Diseases San Francisco 2011 Nov 6-9   View More Conference Reports...   Coming of AGE. A guide to ageing well with HIV - 06/15/11 La informacion Que Necesitas Sobre el VIH - 06/15/10 New Goals and New Drugs for People With Heavy Anti-HIV Drug Experience - 06/05/07 Do you have HIV/HCV Coinfection? - 11/28/06 HIV 101 : The Basics - 11/28/06 VIH 101 : Lo Basico - in Spanish - 11/28/06 HIV 102 : Care and Treatment of HIV - 11/28/06 VIH 102 : Cuidado Y Tratamiento del VIH - in Spanish - 11/28/06 Hepatitis C and Hepatitis C Co-Infection Handbook PDF Version V 11/08/05 Download More NATAP Publications... Support provided by: Abbott, Boehringer-Ingelheim, Bristol-Myers Squibb, Gilead, GlaxoSmithKline, Merck, Roche, Schering-Plough, Tibotec, Vertex   Patient Assistance Programs for HCV Therapy from the Drug Manufacturers: Pegylated Interferon and ribavirin If you cannot get reimbursement or coverage for pegylated interferon and ribavirin the manufacturers of pegylated interferon have reimbursement programs which supply free drugs if you qualify. These programs will first help you try to identify sources for reimbursement.   Schering makes Peg-Intron and ribavirin (Rebetol): Call 1-800-521-7157. Roche makes Pegasys and ribavirin (Copegus): 1-800-387-1258.   New Pegasys Patient Assistance Program   has generous provisions for patients who want to start HCV therapy with Pegasys and are uninsured. Since Roche & Genentech merged the Genentech Access Solutions P rogram took over this program starting Sept 1 2010 and as I say it is a generous transparent program.   http://www.pegasysaccesssolutions.com   866 422-2377